Answer
Evra is contraindicated in women with hepatic impairment and has not been studied in this population.
Sources for this answer
- EVRA 203 micrograms/24 hours + 33.9 micrograms/24 hours transdermal patchGedeon Richter (UK) Ltd · emc · SmPC §4.2 Posology and method of administration · Version 3Document updated
Sources checked